ROP:SWX
Roche Holding AG Genussscheine
CHF 345.50
arrow_downward
-0.63%(-2.20) 1D
Sep 10, 5:30:44 PM GMT+2 · CHF
search
All symbols
1D
5D
1M
6M
YTD
1Y
5Y
MAX
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for ROP...
Open
CHF 350.00
High
CHF 350.00
Low
CHF 343.10
Mkt. cap
280.50B
Avg. vol.
868.12K
Volume
591.75K
Dividend
2.84%
Quarterly dividend
CHF 2.45
Ex-dividend date
Mar 27, 2025
P/E ratio
22.54
52-wk high
CHF 375.80
52-wk low
CHF 291.00
EPS
CHF 15.33
Shares outstanding
702.56M
No. of employees
113K
Open
CHF 350.00
High
CHF 350.00
Low
CHF 343.10
Mkt. cap
280.50B
Avg. vol.
868.12K
Volume
591.75K
Dividend
2.84%
Quarterly dividend
CHF 2.45
Ex-dividend date
Mar 27, 2025
P/E ratio
22.54
52-wk high
CHF 375.80
52-wk low
CHF 291.00
EPS
CHF 15.33
Shares outstanding
702.56M
No. of employees
113K
News stories
From web sources and news partners
Finimize
·
1 hour ago
Swiss Stocks Slip As The ECB Tightens Again
Zacks Investment Research
·
2 hours ago
Roche Gets FDA Priority Tag for Enspryng in Rare Autoimmune Disorder
ad-hoc-news.de
·
11 hours ago
Roche Holding stock heads into the open after a 0.8 percent drop
Stock Titan
·
12 hours ago
A drug cut relapse risk by 68% in a rare nerve disease with no approved treatment
Profile
F. Hoffmann-La Roche AG, commonly known as Roche, is a Swiss multinational holding healthcare company that operates worldwide under two divisions: Pharmaceuticals and Diagnostics. Its holding company, Roche Holding AG, has shares listed on the SIX Swiss Exchange. The company headquarters are located in Basel.
Roche is the fifth-largest pharmaceutical company in the world by revenue and the leading provider of cancer treatments globally. In 2023, the company’s seat in Forbes Global 2000 was 76.
The company owns the American biotechnology company Genentech, which is a wholly owned independent subsidiary, and the Japanese biotechnology company Chugai Pharmaceuticals, as well as the United States–based companies Ventana and Foundation Medicine. Roche's revenues during fiscal year 2020, were 58.32 billion Swiss francs. Descendants of the founding Hoffmann and Oeri families own slightly over half of the bearer shares with voting rights, with Swiss pharma firm Novartis owning a further third of its shares until 2021.
F. Hoffmann-La Roche is a full member of the European Federation of Pharmaceutical Industries and Associations. Wikipedia
About Roche Holding AG Genussscheine
CEOThomas Schinecker
Employees113K
FoundedOct 1, 1896
HeadquartersBasel, Basel City, Switzerland
SectorPharmaceutical industry
Websiteroche.com